Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Shares, par value $0.0000000341740141 per share
-
Shares outstanding
-
695,088,397
-
Total 13F shares
-
545,872,779
-
Share change
-
+45,555,957
-
Total reported value
-
$6,375,349,918
-
Put/Call ratio
-
41%
-
Price per share
-
$11.68
-
Number of holders
-
205
-
Value change
-
+$537,705,852
-
Number of buys
-
136
-
Number of sells
-
73
Institutional Holders of Roivant Sciences Ltd. - Common Shares, par value $0.0000000341740141 per share (ROIV) as of Q3 2023
As of 30 Sep 2023,
Roivant Sciences Ltd. - Common Shares, par value $0.0000000341740141 per share (ROIV) was held by
205 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
545,872,779 shares.
The largest 10 holders included
QVT Financial LP, VIKING GLOBAL INVESTORS LP, SB INVESTMENT ADVISERS (UK) LTD, FMR LLC, MORGAN STANLEY, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, Patient Square Capital LP, BAKER BROS. ADVISORS LP, and T. Rowe Price Investment Management, Inc..
This page lists
205
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.